The GFM1 gene helps mitochondria, the parts of your cells that make energy, build the proteins they need to work properly. If this gene does not work well, cells may struggle to make enough energy, especially in the brain, muscles, and liver. People with pathogenic variants in the GFM1 gene can develop a mitochondrial condition that may cause developmental delay, low muscle tone, feeding problems, seizures, or liver disease. Symptoms often begin in infancy, although severity can vary from person to person.
What is a gene?
Genes are pieces of DNA that carry instructions cells use to make molecules or manage activities throughout the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
GFM1Gene function
What if the gene works
The GFM1 gene helps mitochondria, the cell’s energy centers, make key proteins for energy production. This supports steady function in tissues with high energy needs, including the brain, muscles, and liver.
Risk
What if the gene does not work
More severe variants in the GFM1 gene can cause a mitochondrial condition with developmental delay, poor growth, lactic acidosis, and liver or brain problems, often starting in infancy. Milder variants may start later and vary more.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently tailored specifically to pathogenic variants in the GFM1 gene. Management is supportive and based on the person’s symptoms and affected organs rather than a GFM1-specific medicine.
Conditions associated with GFM1
Gene function
What if the gene works
Inside your mitochondria, the GFM1 gene helps your cells make a small set of proteins they need for daily energy use. These proteins are built inside mitochondria, the parts of cells that turn food into usable energy. This is the core of what the GFM1 gene does in the body every day.
The GFM1 gene helps the mitochondrial ribosome, the protein making machine inside mitochondria, add each new piece in the right order. This keeps protein production moving forward smoothly.
Its protein helps shift the genetic message and the growing protein chain through the mitochondrial ribosome after each step. This makes room for the next protein building block to be added.
By supporting mitochondrial protein production, the GFM1 gene helps mitochondria assemble key parts of the cell's energy system. This supports steady energy release in tissues that work hard every day, such as the brain, muscles, and liver.
What is a variant?
Genetic variants are small differences in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GFM1 gene can weaken or destabilize a protein that helps mitochondria make key energy related proteins, so mitochondrial protein production may slow or stop. This explains how GFM1 gene variants affect mitochondrial function: some changes leave partial activity, while more disruptive variants can sharply reduce protein building and the cell’s energy output. In conditions linked to the GFM1 gene, less remaining activity often goes along with earlier onset and more severe features.
How variants are linked to conditions
Pathogenic variants in the GFM1 gene cause a rare mitochondrial condition called combined oxidative phosphorylation deficiency 1. In people with the GFM1 gene related mitochondrial disease, doctors may see early feeding problems, poor growth, developmental delay, low muscle tone, seizures, or liver involvement. The exact pattern can vary from person to person, but a disease-causing variant in the GFM1 gene is a confirmed genetic diagnosis rather than a general risk marker.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant connected with a condition suggests a possible association rather than a confirmed diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GFM1, risk is mainly shaped by inheritance: it usually becomes a health condition only when both copies of the gene carry a disease-causing change. There is not enough evidence to say that diet, exercise, or other lifestyle changes lower the chance of having a GFM1-related condition, though illness or other body stress can make symptoms worse in people already living with it.
Inheritance of GFM1 variants
Variants in the GFM1 gene are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the GFM1 gene from each parent, and parents who carry one variant are typically unaffected carriers. For families looking into the GFM1 inheritance pattern, when both parents are carriers, each pregnancy has a 25% chance of a child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant.
What does my GFM1 result mean for my family?
For GFM1, the main family implication is usually a recessive pattern. Parents of an affected child are often healthy carriers, and brothers or sisters may also be affected or may be carriers. Other close relatives, such as aunts, uncles, and cousins, may also carry the same change in the GFM1 gene.
Genetic information
Genetic testing
How you find out about variants
To understand how genetic testing for GFM1 works, a lab reads the DNA code in the GFM1 gene from a blood or saliva sample. It looks for variants that may explain a person’s symptoms. Results can help confirm a genetic diagnosis and support family testing when needed.
When should I consider getting a genetic test?
Consider testing for the GFM1 gene if a baby or child has signs of a mitochondrial condition, such as poor feeding, low muscle tone, developmental delay, seizures, or liver problems. It can also help when a GFM1 change is already known in the family and relatives want to see whether they carry the same change.
A genetic result is only one part of your health story
Genetic findings can provide meaningful insight, but how much they show depends on the condition and the kind of variant present. Over time, factors such as lifestyle, environment, age, and medical history also affect how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment works well for one person but not as well for another, or why side effects can differ. These differences are common and are one part of the bigger picture alongside age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects can be. This information can support treatment decisions that are more informed and more individualized. If you want to explore the topic further, you can learn more in the LearnHub.
Drugs influenced by the GFM1 gene
When should I seek medical advice?
There is not yet strong, widely accepted evidence that this gene should be used to guide medicine choices. If you have questions about side effects, medicine changes, or your overall health, speak with your doctor or pharmacist.
History
The GFM1 gene entered the medical literature as researchers studying unexplained mitochondrial disease began connecting certain patterns of liver and brain illness to a shared genetic cause. In recent decades, knowledge has built on a long tradition of observing inherited traits. In the early 2000s, pathogenic variants in the GFM1 gene were identified in children with combined oxidative phosphorylation deficiency, helping clarify a condition that had previously been recognized mainly by its clinical features and laboratory findings. As more families were described, doctors saw that the presentation could vary, even within the same broad diagnosis. These reports gradually shaped today’s understanding of GFM1-related disease and improved the way cases are classified in genetic medicine.